Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1405 to 1409 of 1409 entries
Sorted by: Best Match Show Resources per page
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression.

Cancer immunology research

Parajuli G, Tekguc M, Wing JB, Hashimoto A, Okuzaki D, Hirata T, Sasaki A, Itokazu T, Handa H, Sugino H, Nishikawa Y, Metwally H, Kodama Y, Tanaka S, Sabe H, Yamashita T, Sakaguchi S, Kishimoto T, Hashimoto S.
PMID: 34006522
Cancer Immunol Res. 2021 Aug;9(8):862-876. doi: 10.1158/2326-6066.CIR-21-0014. Epub 2021 May 18.

The acquisition of mesenchymal traits leads to immune evasion in various cancers, but the underlying molecular mechanisms remain unclear. In this study, we found that the expression levels of AT-rich interaction domain-containing protein 5a (Arid5a), an RNA-binding protein, were...

Cite
Parajuli G, Tekguc M, Wing JB, et al. Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer Immunol Res. 2021;9(8):862-876doi: 10.1158/2326-6066.CIR-21-0014.
Parajuli, G., Tekguc, M., Wing, J. B., Hashimoto, A., Okuzaki, D., Hirata, T., Sasaki, A., Itokazu, T., Handa, H., Sugino, H., Nishikawa, Y., Metwally, H., Kodama, Y., Tanaka, S., Sabe, H., Yamashita, T., Sakaguchi, S., Kishimoto, T., & Hashimoto, S. (2021). Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer immunology research, 9(8), 862-876. https://doi.org/10.1158/2326-6066.CIR-21-0014
Parajuli, Gyanu, et al. "Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression." Cancer immunology research vol. 9,8 (2021): 862-876. doi: https://doi.org/10.1158/2326-6066.CIR-21-0014
Parajuli G, Tekguc M, Wing JB, Hashimoto A, Okuzaki D, Hirata T, Sasaki A, Itokazu T, Handa H, Sugino H, Nishikawa Y, Metwally H, Kodama Y, Tanaka S, Sabe H, Yamashita T, Sakaguchi S, Kishimoto T, Hashimoto S. Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression. Cancer Immunol Res. 2021 Aug;9(8):862-876. doi: 10.1158/2326-6066.CIR-21-0014. Epub 2021 May 18. PMID: 34006522.
Copy Download .nbib Format: NLM
Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Asahina Y, Sakaguchi Y, Kajimoto S, Hattori K, Doi Y, Oka T, Kaimori JY, Isaka Y.
PMID: 34280508
Am J Kidney Dis. 2021 Jul 16; doi: 10.1053/j.ajkd.2021.05.022. Epub 2021 Jul 16.

RATIONALE & OBJECTIVE: High anion gap acidosis frequently develops in patients with advanced chronic kidney disease (CKD) and might be involved in kidney injury. Its impact on kidney outcomes, however, has not been well studied. We sought to examine...

Cite
Asahina Y, Sakaguchi Y, Kajimoto S, et al. Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study. Am J Kidney Dis. 2021;doi: 10.1053/j.ajkd.2021.05.022.
Asahina, Y., Sakaguchi, Y., Kajimoto, S., Hattori, K., Doi, Y., Oka, T., Kaimori, J. Y., & Isaka, Y. (2021). Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study. American journal of kidney diseases : the official journal of the National Kidney Foundation, . https://doi.org/10.1053/j.ajkd.2021.05.022
Asahina, Yuta, et al. "Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. (2021). doi: https://doi.org/10.1053/j.ajkd.2021.05.022
Asahina Y, Sakaguchi Y, Kajimoto S, Hattori K, Doi Y, Oka T, Kaimori JY, Isaka Y. Association of Time-Updated Anion Gap With Risk of Kidney Failure in Advanced CKD: A Cohort Study. Am J Kidney Dis. 2021 Jul 16; doi: 10.1053/j.ajkd.2021.05.022. Epub 2021 Jul 16. PMID: 34280508.
Copy Download .nbib Format: NLM
Hepatic actinomycosis after total pancreatectomy: A case report.

International journal of surgery case reports

Sakaguchi T, Hashimoto D, Satoi S, Yamamoto T, Yamaki S, Sekimoto M.
PMID: 34330068
Int J Surg Case Rep. 2021 Aug;85:106212. doi: 10.1016/j.ijscr.2021.106212. Epub 2021 Jul 20.

INTRODUCTION AND IMPORTANCE: Hepatic actinomycosis (HA) is a rare infection mimicking a malignancy. HA after total pancreatectomy for a pancreatic tumor has not been reported.CASE PRESENTATION: A 70-year-old woman with a history of gastrectomy and sigmoidectomy for benign lesions,...

Cite
Sakaguchi T, Hashimoto D, Satoi S, et al. Hepatic actinomycosis after total pancreatectomy: A case report. Int J Surg Case Rep. 2021;85:106212doi: 10.1016/j.ijscr.2021.106212.
Sakaguchi, T., Hashimoto, D., Satoi, S., Yamamoto, T., Yamaki, S., & Sekimoto, M. (2021). Hepatic actinomycosis after total pancreatectomy: A case report. International journal of surgery case reports, 85106212. https://doi.org/10.1016/j.ijscr.2021.106212
Sakaguchi, Tatsuma, et al. "Hepatic actinomycosis after total pancreatectomy: A case report." International journal of surgery case reports vol. 85 (2021): 106212. doi: https://doi.org/10.1016/j.ijscr.2021.106212
Sakaguchi T, Hashimoto D, Satoi S, Yamamoto T, Yamaki S, Sekimoto M. Hepatic actinomycosis after total pancreatectomy: A case report. Int J Surg Case Rep. 2021 Aug;85:106212. doi: 10.1016/j.ijscr.2021.106212. Epub 2021 Jul 20. PMID: 34330068; PMCID: PMC8335620.
Copy Download .nbib Format: NLM
Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization.

Scientific reports

Uematsu S, Sakaguchi H, Sayanagi K, Ikuno Y, Yokoyama A, Asai T, Fukushima Y, Hara C, Sakimoto S, Nishida K.
PMID: 34754047
Sci Rep. 2021 Nov 09;11(1):21947. doi: 10.1038/s41598-021-01557-z.

Although choriocapillaris flow deficit (CFD) around choroidal neovascularization (CNV) is less associated with CNV activity in myopic eyes, no reports are investigating its size as an indicator of CNV activity. We investigated the relationship between CFD and high myopia-related...

Cite
Uematsu S, Sakaguchi H, Sayanagi K, et al. Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization. Sci Rep. 2021;11(1):21947doi: 10.1038/s41598-021-01557-z.
Uematsu, S., Sakaguchi, H., Sayanagi, K., Ikuno, Y., Yokoyama, A., Asai, T., Fukushima, Y., Hara, C., Sakimoto, S., & Nishida, K. (2021). Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization. Scientific reports, 11(1), 21947. https://doi.org/10.1038/s41598-021-01557-z
Uematsu, Sato, et al. "Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization." Scientific reports vol. 11,1 (2021): 21947. doi: https://doi.org/10.1038/s41598-021-01557-z
Uematsu S, Sakaguchi H, Sayanagi K, Ikuno Y, Yokoyama A, Asai T, Fukushima Y, Hara C, Sakimoto S, Nishida K. Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization. Sci Rep. 2021 Nov 09;11(1):21947. doi: 10.1038/s41598-021-01557-z. PMID: 34754047; PMCID: PMC8578547.
Copy Download .nbib Format: NLM
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Nature

Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K.
PMID: 34823256
Nature. 2021 Nov 25; doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25.

During the current coronavirus disease 2019 (COVID-19) pandemic, a variety of mutations have accumulated in the viral genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, at the time of writing, four variants of concern are considered to...

Cite
Saito A, Irie T, Suzuki R, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2021;doi: 10.1038/s41586-021-04266-9.
Saito, A., Irie, T., Suzuki, R., Maemura, T., Nasser, H., Uriu, K., Kosugi, Y., Shirakawa, K., Sadamasu, K., Kimura, I., Ito, J., Wu, J., Iwatsuki-Horimoto, K., Ito, M., Yamayoshi, S., Loeber, S., Tsuda, M., Wang, L., Ozono, S., Butlertanaka, E. P., Tanaka, Y. L., Shimizu, R., Shimizu, K., Yoshimatsu, K., Kawabata, R., Sakaguchi, T., Tokunaga, K., Yoshida, I., Asakura, H., Nagashima, M., Kazuma, Y., Nomura, R., Horisawa, Y., Yoshimura, K., Takaori-Kondo, A., Imai, M., Tanaka, S., Nakagawa, S., Ikeda, T., Fukuhara, T., Kawaoka, Y., & Sato, K. (2021). Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature, . https://doi.org/10.1038/s41586-021-04266-9
Saito, Akatsuki, et al. "Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04266-9
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2021 Nov 25; doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25. PMID: 34823256.
Copy Download .nbib Format: NLM
Showing 1405 to 1409 of 1409 entries